Design of Magnetic Polymeric Particles as a Stimulus-Responsive System for Gastric Antimicrobial Therapy

No abstract is available for this paper.

• Publication year

  2016

• Venue

  AAPS PharmSciTech

• Publication date

  2016-12-13

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1208/s12249-016-0673-1PMID 27966176
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mucoadhesive elementary osmotic pump tablets of trimetazidine for controlled drug delivery and reduced variability in oral bioavailability

  2015cited by this paper
• Magnetic Particles in Biotechnology: From Drug Targeting to Tissue Engineering

  2012cited by this paper
• Antimicrobial activity of metal oxide nanoparticles against Gram-positive and Gram-negative bacteria: a comparative study

  2012cited by this paper
• Effects of partial gelatinization on structure and thermal properties of corn starch after spray drying

  2012cited by this paper
• Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs.

  2012cited by this paper
• Preparation, characterization and release of amoxicillin from cellulose acetate and poly(vinyl pyrrolidone) coaxial electrospun fibrous membranes

  2011cited by this paper
• pH-sensitive Eudragit nanoparticles for mucosal drug delivery.

  2011cited by this paper
• Magnetite Content Evaluation on Magnetic Drug Delivery Systems by Spectrophotometry: A Technical Note

  2011cited by this paper
• IR, Raman, SERS and DFT study of amoxicillin

  2011cited by this paper
• Mucoadhesive liposomal delivery systems: the choice of coating material

  2011cited by this paper
• Fate of polymeric nanocarriers for oral drug delivery

  2011cited by this paper
• Drug Targeting and other Recent Applications of Magnetic Carriers in Therapeutics

  2010cited by this paper
• Synthesis and characterization of magnetic mesoporous particles.

  2010cited by this paper
• Porous Carriers for Controlled/Modulated Drug Delivery

  2009cited by this paper
• Formulation and Evaluation of Gastroretentive Drug Delivery System of Propranolol Hydrochloride

  2009cited by this paper
• Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues.

  2009cited by this paper
• Barrier properties of mucus.

  2009cited by this paper
• Controlled delivery of ranitidine in the stomach using magnetic field.

  2009cited by this paper
• Host-bacterial interactions in Helicobacter pylori infection.

  2008cited by this paper
• Formulation and Evaluation of Gastroretentive Dosage Forms of Clarithromycin

  2008cited by this paper
• Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus

  2007cited by this paper
• Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradication of Helicobacter pylori.

  2007cited by this paper
• Applications of spray-drying in microencapsulation of food ingredients: An overview

  2007cited by this paper
• Oleic acid coating on the monodisperse magnetite nanoparticles

  2006cited by this paper
• Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications.

  2006cited by this paper
• Effect of sodium diclofenac on the bioavailability of amoxicillin.

  2006cited by this paper
• Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs.

  2005cited by this paper
• Detoxification of blood using injectable magnetic nanospheres: A conceptual technology description

  2005cited by this paper
• Comparative study of alternative methods for the simultaneous determination of Fe+3 and Fe+2 in leaching solutions and in acid mine drainages

  2005cited by this paper
• Hexagonal ordered mesoporous material as a matrix for the controlled release of amoxicillin

  2004cited by this paper
• A Novel Evaluation Method of Gastric Mucoadhesive Property in Vitro and the Mucoadhesive Mechanism of Tetracycline-Sucralfate Acidic Complex for Eradication of Helicobacter pylori

  2004cited by this paper
• Expandable gastroretentive dosage forms.

  2003cited by this paper
• Applications of magnetic nanoparticles in biomedicine

  2003cited by this paper
• APPLICATIONS OF MAGNETIC NANOPARTICLES IN BIOMEDICINE

  2003cited by this paper
• Morphological analysis of pharmaceutical powders

  2002cited by this paper
• Stomach-specific anti-H. pylori therapy. I: Preparation and characterization of tetracyline-loaded chitosan microspheres.

  2002cited by this paper
• Open-label study of a regimen consisting of 1 week of lansoprazole, clarithromycin, and amoxicillin followed by 3 weeks of lansoprazole in healing peptic ulcer and eradicating Helicobacter pylori

  2000cited by this paper
• Gastric retention properties of superporous hydrogel composites.

  2000cited by this paper
• Unique mechanism of Helicobacter pylori for colonizing the gastric mucus.

  2000cited by this paper
• A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 combinations.

  1999cited by this paper
• The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection.

  1997cited by this paper
• Bactericidal and morphological effects of amoxicillin on Helicobacter pylori

  1995cited by this paper
• The gastric cardia in Helicobacter pylori infection.

  1994cited by this paper
• The Bilayer Floating Capsule: A Stomach-Directed Drug Delivery System for Misoprostol

  1992cited by this paper
• Preparation of aqueous magnetic liquids in alkaline and acidic media

  1981cited by this paper
• Antibiotic susceptibility testing by a standardized single disk method.

  1966cited by this paper
• (CONTRIBUTION FROM THE MULTIPLE FELLOWSHIP OF BAUGH AND SONS COMPANY, MELLOX INSTITUTE) The Determination of Pore Volume and Area Distributions in Porous Substances. I. Computations from Nitrogen Isotherms

  1951cited by this paper

• Gastroretentive drug delivery systems: A holy grail in oral delivery.

  2025cites this paper
• Leading Paediatric Infectious Diseases—Current Trends, Gaps, and Future Prospects in Oral Pharmacotherapeutic Interventions

  2024cites this paper
• Applications of Antibacterial Materials with Physiological Responsiveness in Wound Repair

  2023cites this paper
• Recent Advances in Combating Bacterial Infections by Using Hybrid Nano-Systems

  2023cites this paper
• Stimulus-responsive biomaterials for Helicobacter pylori eradication

  2023cites this paper
• Recent advances in mucus-penetrating nanomedicines for oral treatment of colonic diseases

  2023cites this paper
• Treatment of H. pylori infection and gastric ulcer: Need for novel Pharmaceutical formulation

  2023cites this paper
• pH and its applications in targeted drug delivery.

  2022cites this paper
• Manganese oxide nanomaterials for bacterial infection detection and therapy.

  2022cites this paper
• Mushroom-brush transitional conformation of mucus-inert PEG coating improves co-delivery of oral liposome for intestinal metaplasia therapy.

  2022cites this paper
• Polymeric Coatings and Antimicrobial Peptides as Efficient Systems for Treating Implantable Medical Devices Associated-Infections

  2022cites this paper
• Gastroretentive Sustained-Release Tablets Combined with a Solid Self-Micro-Emulsifying Drug Delivery System Adsorbed onto Fujicalin®

  2022cites this paper
• Physically Switchable Antimicrobial Surfaces and Coatings: General Concept and Recent Achievements

  2021cites this paper
• Stimuli-Responsive Polymeric Nanocarriers for Drug Delivery, Imaging, and Theragnosis

  2020cites this paper
• New Smart Antimicrobial Hydrogels, Nanomaterials, and Coatings: Earlier Action, More Specific, Better Dosing?

  2020cites this paper
• DRUG DELIVERY STRATEGIES FOR HELICOBACTER PYLORI INFECTION MANAGEMENT: AN OVERVIEW

  2019cites this paper